Date: 4-6 April 2022
Location: Hilton Gateshead, Newcastle UK
Attendee: Oksana Nikolayenko & Tim Potter
Date: 4-6 April 2022
Location: Hilton Gateshead, Newcastle UK
Attendee: Oksana Nikolayenko & Tim Potter
Date: July 24th-29th, 2022
Venue: Renaissance Tuscany Il Ciocco, Lucca | Barga, Italy
Attendees: Alastair Parkes, Stephane Vandenbeele, Guiseppe D'Angelo, Florian Marro
Evotec will be sponsoring the New Antibacterial Discovery and Development Conference, as well as showcasing its research on-site in Italy.
Our scientific program
Using Probabilistic Approaches and AI/ML to advance antibacterial drug discovery projects
Alastair Parkes, VP Head of Department III, Medicinal Chemistry
Wednesday, 27 July | 11.30 am - 11.50am
Poster Presentation
Intracellular Staphylococcus aureus replicative dynamics monitoring under antibiotics challenges: highlighting persisters.
Florian C. Marro, Research Associate, Mass Spectrometry & Phenomics
Poster Sessions are scheduled 4:30 pm - 6:00 pm from 25-28 July 2022.
If you wish to meet with us in Italy, get in touch via the form below, we will be happy to arrange a meeting.
Learn more about the GRC - New Antibacterial Discovery and Development.
Take a Ride on the Evotec "Data-Driven R&D Autobahn to Cures"
5 Virtual Sessions over 5 Days
Date: 6 - 10 November 2021 Online | 9 - 11 November 2021 Fiera Milano
Location: Virtual
Learn how Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy
Find out about our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of biomarker development, targeting RNA, and our approaches to target validation
Day 1:
Drug Discovery in Evotec Multiverse: Knowledge-driven Integrated R&D
Presented by: Adam Davenport, Tim James and Christophe Boldron
When | Monday 6 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET
Day 2:
The Importance of Precision Medicine: How Biomarkers Optimise Translation from Bench to Bedside and Back
Presented by: Elizabeth van der Kam, Christoph Schaab
When |Tuesday 7 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET
Day 3:
The Early Bird Catches the Helix: Expanding the Druggable Target Space to RNA
Presented by: Steffen Grimm, Hilary Brooks
When | Wednesday 8 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET
Day 4:
Do Firefighters cause Fires? Establishing Real Disease Associations through Target Validation
Presented by: Hauke Cornils, Susan Boyce
When |Thursday 9 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET
Day 5:
Translate your Idea into Product: AI-Driven Antibody Discovery at Evotec
Presented by: Barbara Bachler-Konetzki, Randal Ketchem, Maria Pilla
When | Friday 10 December @ 11am EST | 8am PST | 4pm GMT | 5pm CET
Each session will take approx. 45 min including Q&A. You will need to register for each day separately to reserve your seat.
Tags: Events, Evotec, Just Evotec Biologics
Date: 18th November 2021
Venue: Virtual
Attendee: Dr Alastair Parkes, Group Leader at Evotec will be presenting on "Novel LpxA inhibitors targeting Pseudomonas aeruginosa"
Date: 15th-16th November 2021
Location: ENS Campus Gerland, Lyon, France
Attendee: Antoine Alam, VP Virology will be presenting on "CD40 agonists boost IFN-induced signaling pathway and subsequent anti-HBV response in vitro and in vivo"
Huge Watson, Virology Clinical Development will be presenting a poster entitled "Household clustering suggests a novel chemoprophylaxis trial design for an arboviral disease"
Francesca Bernardini, VP In Vitro Biology, Sébastien Coyne, Group Leader In Vitro Biology, Kara Carter, Virology Entrepreneur in Residence, Lilia Boucinha, Team Leader, Bioinformatics
Date: 26th -27th October 2021
Location: London, UK
Evotec is a sponsor of Discovery UK 2021 (organised by Oxford Global)
Our Senior Vice President, Global Head of Protein Sciences, John Barker will present on "Discovery of Novel UDP-N-Acetylglucosamine Acyltransferase (LpxA) Inhibitors With Activity Against Pseudomonas aeruginosa" on October 27th at 9:50am in the Molecular Drug Design & Medicinal Chemistry, & The Optimisation of HITS stream
Our delegates: Jason Brown, Oksana Nikolayenko, John Barker
Date: 28th -29th October 2021
Location: Wequassett Resort & Golf Club in Chatham, MA on Cape Cod, US
Evotec is a sponsor of Convergence Forum 2021
Our Global Head, Integrated Drug Discovery, Karen Lackey will be speaking at the mainstage session on Thursday, October 28th 11:45 AM - 12:30 PM on “Today's Applications of AI in Drug Discovery — and What Comes Next” with Kristen Fortney, PhD, CEO and co-founder at BioAge - Moderator: Rich Kivel, Managing Director, GrayBella Capital
Attendees: Ryan Brady, Itta MacNevin, Karen Lackey
Date: 19-20/10/2021
Location: The Exhibition Centre, ACC, Liverpool
Attendee: Oksana Nikolayenko
Date: 25th -28th October 2021
Location: Virtual event
Evotec is a sponsor of BIOEurope 2021 - View the event agenda and register to the on-demand sessions to listen from our experts:
Interview | On Demand | Cord Dohrmann, Evotec CSO
How to build an innovative pipeline
Business Development Stream
Panel Discussion | On Demand | Bernd Muehlenweg - SVP, Innovate Strategic Initatives at Evotec
The speed of life science innovation
Technologies such as CRISPR and mRNA have been hailed as 'new science' but these therapies are the result of long lab hours, years of clinical development, and intensive research by solo scientists and collaborative teams. This session will consider the fundamental character of the lifescience discovery process. Are there tools that have emerged that that ease the 25-year discovery process to something shorter? What role does collaboration and communication play in facilitating advancements? And what modalities emerging now could be the breakthroughs of the future?
Biotech Ecosystem Stream
Presentation | On Demand | Thomas Hanke, Evotec Head of Academic Partnerships at Evotec
Diversifying your funding options is key to startup success
What type of funding is best suited to you? VC's are not always the perfect fit and the right route to take when looking for funding sources to start a successful company. This panel will explore alternative funding sources.
Business Development Stream
Don't miss Evotec's showcase on cell and gene therapy published in the EBR's annual BIO-Europe 2021 Supplement: "Next Generation Treatments to Cure Chronic Diseases"
Connect via PartneringOne to meet with them and all our experts at BioEurope or email us at info@evotec.com
Our team at BioEurope 2021
Cord Dohrmann, Bernd Mühlenweg, Thomas Hanke, Adam Stoten, Margit Wissenbach, Fred Somny, Daniel Ozanne, Sneha Kumar
Date: 20th - 22nd October 2021
Location: Pisa, Italy (Officine Garibaldi)
Attendees: Manuela Medelin
BraYn stands for “Brainstorming Research Assembly for Young Neuroscientists”. It is an initiative which aims to create a congress specifically intended for young researchers under the age of 40 working in the field of Neuroscience.
Tags: Events, Neuroscience, Evotec